Dental sedation study pulled before it began
NCT ID NCT06793358
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to see if a combination of remimazolam and fentanyl could safely sedate patients during dental extractions lasting 30 minutes or less. It planned to enroll healthy adults needing tooth removal. However, the trial was withdrawn before any participants were enrolled, so no data was collected.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- remimazolam and fentanyl
- What this could lead to
- If it had worked, this could have pointed toward a safe, fast-acting sedation option for short dental procedures.
- What could go wrong
- The study was withdrawn before any participants were enrolled, so no results are available. The combination had not been tested in dental extractions before.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DENTAL EXTRACTION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Indiana University School of Dentistry (IUSD)
Indianapolis, Indiana, 46202, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.